NuGEN Announces Takara Bio as Japanese Distributor
NuGEN Strengthens its Global Distribution Adding a Strong Partner in Asia Pacific
San Carlos, Calif.—June 8, 2010—NuGEN, the provider of innovative RNA and DNA sample preparation technologies that enable breakthrough genomic analysis, today announced it has signed a non-exclusive agreement with Takara Bio to distribute the full spectrum of NuGEN's next-generation sequencing, microarray and q-PCR nucleic acid amplification and sample preparation products in Japan, South Korea and China. In addition, Takara is authorized to offer services using NuGEN products in the same territory.
"Takara Bio is committed to offering technology solutions that enable significant advancements in life sciences," said Tsuyoshi Miyamura, General Manager, Marketing at Takara Bio. "We're pleased that we can now offer NuGEN's solutions, which serve a broad and unique role in genomic analysis. These offerings complement our current portfolio of leading products as well as custom services in molecular biology and genomics including next-generation sequencing, PCR, real time PCR and microarrays.
"Takara Bio is a leader in delivering life sciences products to the Asia Pacific market place and its experience with key organizations provides an expansive opportunity to the NuGEN portfolio," said Sue Pandey, Ph.D., Vice President of Field Operations at NuGEN. "NuGEN's distribution agreement with Takara represents an essential component of our overall global expansion strategy. We are confident that Takara Bio will be an ideal partner to represent NuGEN and deliver the outstanding support and services to our customers."
Takara Bio is an important addition to NuGEN's international distribution channel, joining distributors in Japan, Singapore and Australia, as well as service providers in India, China and Taiwan. NuGEN also has field operations in Europe.
NuGEN provides revolutionary RNA and DNA sample preparation technologies that enable life scientists to do more with less. With innovative reagent solutions that are quick and easy to use, NuGEN empowers researchers to prepare genomic samples of any size, from almost any source, regardless of the intended application or technology platform. Committed to advancing the life sciences, NuGEN ensures robust and reproducible results for researchers seeking to predict disease risk and drug response, potentially shortening the path to treatment.
About Takara Bio Inc.
Takara Bio Inc. is an innovative biotechnology company based in Shiga, Japan. As a world leader in biotechnology research and development, Takara Bio was the first company to market PCR technology in Japan and is also the developer of the RetroNectin® reagent, which is a world-standard in gene therapy protocols. In addition to providing research reagents and equipment to the life science research market, Takara Bio has active research and product development activities in the fields of gene and cell-based therapy, and agricultural biotechnology; and is committed preventing disease and improving the quality of life for all people through the use of biotechnology. Through strategic alliances with other industry leaders, the Company aims to extend its reach around the world. More information is available at http://www.takara-bio.com.
Yan Zhang, Ph.D.
The Racepoint Group on Behalf of NuGEN, Inc.